Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Endothelial Expression of Scavenger Receptor Class B, Type I Protects against Development of Atherosclerosis in Mice.

Vaisman BL, Vishnyakova TG, Freeman LA, Amar MJ, Demosky SJ, Liu C, Stonik JA, Sampson ML, Pryor M, Bocharov AV, Eggerman TL, Patterson AP, Remaley AT.

Biomed Res Int. 2015;2015:607120. doi: 10.1155/2015/607120. Epub 2015 Oct 4.

2.

The Human ABCG1 Transporter Mobilizes Plasma Membrane and Late Endosomal Non-Sphingomyelin-Associated-Cholesterol for Efflux and Esterification.

Neufeld EB, O'Brien K, Walts AD, Stonik JA, Malide D, Combs CA, Remaley AT.

Biology (Basel). 2014 Dec 4;3(4):866-91. doi: 10.3390/biology3040866.

3.

Cellular Localization and Trafficking of the Human ABCG1 Transporter.

Neufeld EB, O'Brien K, Walts AD, Stonik JA, Demosky SJ, Malide D, Combs CA, Remaley AT.

Biology (Basel). 2014 Nov 14;3(4):781-800. doi: 10.3390/biology3040781.

4.

Hydrophobic amino acids in the hinge region of the 5A apolipoprotein mimetic peptide are essential for promoting cholesterol efflux by the ABCA1 transporter.

Sviridov DO, Andrianov AM, Anishchenko IV, Stonik JA, Amar MJ, Turner S, Remaley AT.

J Pharmacol Exp Ther. 2013 Jan;344(1):50-8. doi: 10.1124/jpet.112.198143. Epub 2012 Oct 5.

5.

Diet-induced weight loss in overweight or obese women and changes in high-density lipoprotein levels and function.

Aicher BO, Haser EK, Freeman LA, Carnie AV, Stonik JA, Wang X, Remaley AT, Kato GJ, Cannon RO 3rd.

Obesity (Silver Spring). 2012 Oct;20(10):2057-62. doi: 10.1038/oby.2012.56. Epub 2012 Mar 8.

6.

Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis.

Vaisman BL, Demosky SJ, Stonik JA, Ghias M, Knapper CL, Sampson ML, Dai C, Levine SJ, Remaley AT.

J Lipid Res. 2012 Jan;53(1):158-67. doi: 10.1194/jlr.M018713. Epub 2011 Oct 27.

7.

High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism.

Sekine Y, Demosky SJ, Stonik JA, Furuya Y, Koike H, Suzuki K, Remaley AT.

Mol Cancer Res. 2010 Sep;8(9):1284-94. doi: 10.1158/1541-7786.MCR-10-0008. Epub 2010 Jul 29.

8.

Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.

D'Souza W, Stonik JA, Murphy A, Demosky SJ, Sethi AA, Moore XL, Chin-Dusting J, Remaley AT, Sviridov D.

Circ Res. 2010 Jul 23;107(2):217-27. doi: 10.1161/CIRCRESAHA.110.216507. Epub 2010 May 27.

9.

Asymmetry in the lipid affinity of bihelical amphipathic peptides. A structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides.

Sethi AA, Stonik JA, Thomas F, Demosky SJ, Amar M, Neufeld E, Brewer HB, Davidson WS, D'Souza W, Sviridov D, Remaley AT.

J Biol Chem. 2008 Nov 21;283(47):32273-82. doi: 10.1074/jbc.M804461200. Epub 2008 Sep 19.

10.

Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides.

Gomaraschi M, Calabresi L, Rossoni G, Iametti S, Franceschini G, Stonik JA, Remaley AT.

J Pharmacol Exp Ther. 2008 Feb;324(2):776-83. Epub 2007 Nov 27.

PMID:
18042829
11.

Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells.

Stonik JA, Remaley AT, Demosky SJ, Neufeld EB, Bocharov A, Brewer HB.

Biochem Biophys Res Commun. 2004 Sep 3;321(4):936-41.

PMID:
15358117
12.

The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.

Neufeld EB, Stonik JA, Demosky SJ Jr, Knapper CL, Combs CA, Cooney A, Comly M, Dwyer N, Blanchette-Mackie J, Remaley AT, Santamarina-Fojo S, Brewer HB Jr.

J Biol Chem. 2004 Apr 9;279(15):15571-8. Epub 2004 Jan 27.

13.

Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway.

Remaley AT, Thomas F, Stonik JA, Demosky SJ, Bark SE, Neufeld EB, Bocharov AV, Vishnyakova TG, Patterson AP, Eggerman TL, Santamarina-Fojo S, Brewer HB.

J Lipid Res. 2003 Apr;44(4):828-36. Epub 2003 Jan 16.

14.

The ABCA1 transporter functions on the basolateral surface of hepatocytes.

Neufeld EB, Demosky SJ Jr, Stonik JA, Combs C, Remaley AT, Duverger N, Santamarina-Fojo S, Brewer HB Jr.

Biochem Biophys Res Commun. 2002 Oct 4;297(4):974-9.

PMID:
12359250
15.

Cellular localization and trafficking of the human ABCA1 transporter.

Neufeld EB, Remaley AT, Demosky SJ, Stonik JA, Cooney AM, Comly M, Dwyer NK, Zhang M, Blanchette-Mackie J, Santamarina-Fojo S, Brewer HB Jr.

J Biol Chem. 2001 Jul 20;276(29):27584-90. Epub 2001 May 10.

16.

Apolipoprotein specificity for lipid efflux by the human ABCAI transporter.

Remaley AT, Stonik JA, Demosky SJ, Neufeld EB, Bocharov AV, Vishnyakova TG, Eggerman TL, Patterson AP, Duverger NJ, Santamarina-Fojo S, Brewer HB Jr.

Biochem Biophys Res Commun. 2001 Jan 26;280(3):818-23.

PMID:
11162594
17.

Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux.

Remaley AT, Schumacher UK, Stonik JA, Farsi BD, Nazih H, Brewer HB Jr.

Arterioscler Thromb Vasc Biol. 1997 Sep;17(9):1813-21.

PMID:
9327782
18.

Carboxyl-terminal domain truncation alters apolipoprotein A-I in vivo catabolism.

Schmidt HH, Remaley AT, Stonik JA, Ronan R, Wellmann A, Thomas F, Zech LA, Brewer HB Jr, Hoeg JM.

J Biol Chem. 1995 Mar 10;270(10):5469-75.

19.

Human apolipoprotein A-I. Post-translational modification by covalent phosphorylation.

Beg ZH, Stonik JA, Hoeg JM, Demosky SJ Jr, Fairwell T, Brewer HB Jr.

J Biol Chem. 1989 Apr 25;264(12):6913-21.

24.
25.

Reversible inactivation of 3-hydroxy-3-methylglutaryl coenzyme A reductase: reductase kinase and mevalonate kinase are separate enzymes.

Beg ZH, Stonik JA.

Biochem Biophys Res Commun. 1982 Sep 30;108(2):559-66. No abstract available.

PMID:
6293495
26.

Isolation and immunological characterization of 3-hydroxy-3-methylglutaryl coenzyme A reductase from human liver.

Beg ZH, Stonik JA, Brewer HB Jr.

Biochem Biophys Res Commun. 1982 Aug;107(3):1013-20. No abstract available.

PMID:
6814428
27.

In vitro and in vivo phosphorylation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase and its modulation by glucagon.

Beg ZH, Stonik JA, Brewer HB Jr.

J Biol Chem. 1980 Sep 25;255(18):8541-5. No abstract available.

29.

3-Hydroxy-3-methylglutaryl coenzyme A reductase from avian liver. Catalytic properties.

Beg ZH, Stonik JA, Brewer HB Jr.

Biochim Biophys Acta. 1979 Jan 29;572(1):83-94.

PMID:
32916
30.
31.

Solubilization of 3-hydroxy-3-methylglutaryl coenzyme A reductase from rat and chicken liver microsomes.

Beg ZH, Stonik JA, Brewer HB Jr.

Anal Biochem. 1978 Jun 1;86(2):531-5. No abstract available.

PMID:
655413
32.

Purification and characterization of 3-hydroxy-3-methylglutaryl coenzyme A reductase from chicken liver.

Beg ZH, Stonik JA, Brewer HB Jr.

FEBS Lett. 1977 Aug 1;80(1):123-9. No abstract available.

Supplemental Content

Loading ...
Support Center